Measurement Repeatability in Contemporary Aberrometry

February 19, 2016 updated by: Bruce Allan, Moorfields Eye Hospital NHS Foundation Trust

A Comparative Study of Measurement Repeatability for Two Aberrometers

Wavefront scans are a common form of diagnostic test applied in preparing patients for laser eye surgery. An optical map of the eye is created by wavefront scanning, and information from these maps is used to program lasers used to correct focusing errors in the eye. Here the investigators are comparing how repeatable measurements are with a new wavefront scanner and one that is already in widespread use.

Study Overview

Status

Unknown

Conditions

Detailed Description

Aberrometers are used to measure each element of defocus (aberration) in an optical system. In LASIK, information derived from aberrometry (scans performed using aberrometers) is used to program the pattern of laser pulses delivered by an excimer laser in therapeutic reshaping of the cornea to correct defocus. To do this accurately, aberrometry findings need to be repeatable and correspond closely to manifest refraction. Here the investigators compare repeatability of measurements for a new aberrometer (Peramis) versus the aberrometer most widely used in contemporary wavefront guided laser vision correction (iDesign).

The test aberrometer will be:

Peramis (Schwind Eye-tech Solutions, Kleinostheim, Germany).

Control aberrometer will be:

iDesign (AMO, Santa Clara, CA)

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Myopic LASIK candidates (manifest refraction spherical equivalent range 0 to -10 diopters with up to 6 diopters cylinder) or patients attending corneal service with stage II-III keratoconus or post-keratoplasty

Exclusion Criteria:

  • Visually significant co-pathology (CDVA<6/6) other than irregular astigmatism;
  • Patients unable to complete a sequence of 2 good scans (acquisition diameter >5mm) in one eye within 4 attempts

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Myopia (Peramis)
Peramis aberrometry: 30 consecutive LASIK candidates with myopia and regular astigmatism who agree to participate in the study will have up to 4 aberrometry scans acquired consecutively using the Peramis (test) aberrometer.
A non-invasive photographic scan sequence acquired in under 10 seconds
Other Names:
  • Wavefront scanning
Active Comparator: Myopia (iDesign)
iDesign aberrometry: The same 30 consecutive LASIK candidates scanned in the Myopia (Peramis) arm will also have up to 4 aberrometry scans acquired consecutively using the iDesign aberrometer (control) aberrometer. The order of scans (Peramis and iDesign) will be randomised.
A non-invasive photographic scan sequence acquired in under 10 seconds
Other Names:
  • Wavefront scanning
Experimental: Irregular astigmatism (Peramis)
Peramis aberrometry: 30 consecutive cases with stage II-III keratoconus or post corneal transplantation cases with irregular astigmatism will have up to 4 aberrometry scans acquired consecutively using the Peramis (test) aberrometer
A non-invasive photographic scan sequence acquired in under 10 seconds
Other Names:
  • Wavefront scanning
Active Comparator: Irregular astigmatism (iDesign)
iDesign aberrometry: 30 consecutive cases with stage II-III keratoconus or post corneal transplantation cases with irregular astigmatism will also have up to 4 aberrometry scans acquired consecutively using the iDesign aberrometer (control) aberrometer. The order of scans (Peramis and iDesign) will be randomised.
A non-invasive photographic scan sequence acquired in under 10 seconds
Other Names:
  • Wavefront scanning

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
2nd to 4th order aberrations (5mm pupil).
Time Frame: <10 seconds
M, J0, J45, Coma, Trefoil, Spherical Aberration. Different types of defocus or aberration can be defined and measured by wavefront scanning. Aberrations are classified and quantified by a mathematical treatment called Zernike analysis in which harmonic elements of the waveform of the light detected by the wavefront sensor (aberrometer) are quantified in sequence, starting with simple (lower order) waveforms such as sphere and cylinder (M, J0, J45) corrected in a normal spectacle prescription, and progressing through more complex (higher order) waveforms including, coma, trefoil and spherical aberration which may influence quality of vision. The amount of each aberration varies as a function of pupil size. So pupil size is standardised at 5mm diameter for quantification.
<10 seconds

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
% of patients with qualifying scan sequence
Time Frame: <5 minutes
% of patients in whom two 5mm diameter aberrometry scans can be acquired within 4 attempts
<5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bruce Allan, MD FRCOphth, Moorfields Eye Hospital NHS Foundation Trust

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2016

Primary Completion (Anticipated)

June 1, 2016

Study Completion (Anticipated)

September 1, 2016

Study Registration Dates

First Submitted

February 7, 2016

First Submitted That Met QC Criteria

February 19, 2016

First Posted (Estimate)

February 22, 2016

Study Record Updates

Last Update Posted (Estimate)

February 22, 2016

Last Update Submitted That Met QC Criteria

February 19, 2016

Last Verified

February 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ALLB1019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

The investigators plan to publish summary descriptive data and analyses. Anonymised individual data will be available to systematic reviewers on request.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Refractive Errors

Clinical Trials on Peramis aberrometry

3
Subscribe